The 2nd Annual Pharmacovigilance Forum continues to investigate the impact of the evolving regulation both on the national and international level. It reveals such strategies and best practices that can be adopted in order to overcome such problems as risk mitigation, data collection and management, monitoring adverse drug reactions and challenges in the field of QPPV. Furthermore, the event provides updates on the assessment of PRAC, PSUR principles and the newly launched Black Triangle Symbol legislation.The Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.
Doris Irene Stenver
Member of the Pharmacovigilance Risk Assessment Committee
European Medicines Agency
Sr. Pharmacovigilance Leader
Corporate Vice president
Novo Nordisk A/S
Global Head of Pharmacovigilance, EU QPPV
Bert Van Leeuwen
Deputy Qualified Person for Pharmacovigilance (QPPV)
Astellas Pharma Europe
Senior Specialist Medical Safety & Epidemiology
Safety Risk Lead
Director Pharmacovigilance, QPPV Bavarian
Professor Saad Shakir
Drug Safety Research Unit
Assoc.Prof. of Basic & Clinical Pharmacology
Faculty of Medicine & Pharmacy
Takeda Pharmaceuticals Europe
Peter De Veene
Clinical Safety and Pharmacovigilance
Head of Brussels Office
German Pharmaceutical Industry Association (BPI)
Head of Safety and QPPV
Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensing.com) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.
"I wish to thank you for inviting me to your Conference which was very interesting and excellently organized."
MSc Programme in Human Resource Management - Athens University of Economics and Business – Greece
"Thank you very much for the excellent experience"
HR Specialist - Millenium BCP – Portugal
"Thank you for what was overall a very good conference: interesting, right speakers, right audience, very good facilitation and proper organization."
HR Director – LibanPost – Lebanon
"The best HR Conference I have ever attended. Congrats and keep up the good job."
Head of HR - Banca Comerciala Carpatica – Romania
"Thanks for a good conference. Many interesting presentations!"
Managing Director – PharmaEvidence
"It was very good to meet you in Frankfurt, and congratulations on organizing such a successful event."
Clinical Director - All Wales Therapeutics and Toxicology Centre - United Kingdom
"It was an excellent one under GLC’s organization; I am honored for being a part of it. I really appreciated of your organization during the Forum from which I benefited a lot, thank you very much for everything indeed, you are wonderful."
Chief Auditor – Central Bank of Turkey –Turkey
"Excellent results. I really enjoyed the conference myself. Think it was well organized and good participation from the audience."
Chief Auditor for Functions and Capital Resolution Group - Royal Bank of Scotland, Internal Audit
"The organization was fantastic"
Director Internal Audit - Bank of Slovenia – Slovenia
"It was a pleasure to attend and speak at the 3rd IA Conference! The environment was outstanding and the presentations were very interesting"
Director of Internal Audit (Head of Group) – Portuguese Mutual Guarantee System (SPGM)
"Thanks a lot for arranging such a good Forum. Thank to GLC for their friendly support"
Head of Internal Audit & Compliance - Eco Trade and Development Bank – Turkey
|GLC - Global Leading Conferences
Hungary H-1134 Budapest, Váci út 19. (Panorama Office Building)
glc(at)glceurope.com +36 1 848 05 32